Population Health Management Market by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers, Healthcare Payers, Employer Groups, Government Bodies) Covid Impact Analysis - Global Forecasts to 2026
[215 Pages Report] The global population health management market is projected to reach USD 46.7 billion by 2026 from USD 24.9 billion in 2021, at a CAGR of 13.4% during the forecast period. In this report, the population health management market has been segmented on the basis of component, mode of delivery, end user, and region.
Population health management solutions enable stakeholders in the healthcare sector to deliver patient-centric care and help in curtailing the high costs associated with healthcare by reducing readmissions, ensuring that only appropriate and optimum interventions are provided to patients. These solutions streamline workflows by ensuring that the processes in care delivery function smoothly.
Government mandates and support for healthcare IT solutions, increasing use of big data analytics, and the need to curtail the escalating healthcare costs are the key factors driving the growth of the population health management market. In addition, the growth of emerging economies (such as Brazil, Russia, India, South Korea, and China), increasing focus on personalized medicine, and the rising focus on value-based medicine are expected to offer lucrative growth opportunities for market players during the forecast period. However, data breaches, lack of skilled analysts, and interoperability issues are adversely impacting the growth of this market.
The global population health management market is projected to reach USD 46.7 billion by 2026 from USD 24.9 billion in 2021, at a CAGR of 13.4% during the forecast period. In this report, the population health management market has been segmented on the basis of component, mode of delivery, end user, and region.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on the Population Health Management Market
Largely unknown before the outbreak began in Wuhan (China) in December 2019, the WHO declared COVID-19, an infectious disease, a pandemic on March 11, 2020.
Countries are trying to prevent further contagion by taking measures such as social distancing, contact tracing, self-quarantining, surveillance, communication, and testing. So far, several countries like India, Brazil, the US, Italy, Spain, Germany, France, and Iran are imposing drastic measures to slow down the spread and control fatalities.
Government agencies have announced special financial aid to develop preventive and curative drugs, purchase critical care medical devices, and ensure the fast-track approval of diagnostic tests. Various organizations, such as the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, are also coming together to accelerate and strengthen the efforts to fight the COVID-19 pandemic.
IMPACT OF COVID-19 ON POPULATION HEALTH MANAGEMENT MARKET
Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities worldwide have been overwhelmed by the large number of patients visiting them daily. The increasing prevalence of COVID-19 has driven the demand for accurate diagnosis and treatment devices in several countries. In this regard, population health management solutions have proven to be very helpful, as they allow healthcare providers to seamlessly integrate solutions such as EHR, patient management, and care management to healthcare payer solutions such as claim management and payment management solutions. Moreover, the rapid spread of this disease worldwide has resulted in lockdowns and restrictions, increasing the demand for electronic data transfer and claim management. This is expected to increase the adoption of population health management in the coming years as well.
The COVID-19 pandemic has also increased the need for social distancing among physicians and other healthcare professionals, which has driven the demand for PHM solutions and the need for the accurate and timely exchange of patient health records and claims data for patients suffering from chronic conditions. In this regard, PHM offers effective tools that provide a framework for the exchange, sharing, and retrieval of electronic health information along with claims data with advanced security. These solutions allow a seamless exchange and interpretation of health-related data among healthcare organizations and patients for clinical and financial decision-making.
Additionally, due to the growing patient volumes, the demand for EMR and EHR platforms to manage complex patient data has increased. Hospitals are increasingly focusing on building their capabilities by integrating their EHR solutions with various other HCIT platforms. Players operating in this market have also integrated their EHR platforms with other IT solutions like PHM and upgraded their software solutions to help healthcare providers manage COVID-19 patients effectively.
Many countries have also been hit by the second wave of COVID-19, resulting in complete lockdowns. Restrictions related to social distancing have led to a slight increase in the use of PHM solutions.
Population Health Management Market Dynamics
Drivers: Need to curtail escalating healthcare costs
The overall cost of healthcare delivery has grown significantly over the past few decades. Factors such as increasing health insurance premiums, the growing demand for quality healthcare services, the rising number of elderly people, and the growing incidence of chronic disorders drive the demand for healthcare services across the globe. Other factors contributing to the high expenditure on healthcare services are patient readmissions, medical errors, and administration costs.
- According to the UN Population Division, the global aging population is expected to increase from 880 million in 2011 to 2 billion by 2050, representing 22% of the world’s population. If left unchecked, healthcare spending will increase by 25% by 2030, largely because of the aging population.
- Currently, the US is facing major challenges in countering the rising healthcare costs. Healthcare accounted for ~17.7% of the US GDP in 2019; this figure is estimated to reach 26.0% by 2035 (the highest across the globe).
- Additionally, according to the CMS and National Health Statistics Group, in 2019, the per capita healthcare expenditure in the US was USD 11,582. According to OECD projections, public expenditure on health and long-term care in OECD countries is set to increase from around 6% of the GDP currently to almost 9% of the GDP by 2030, and as much as 14% by 2060.
Governments and healthcare systems across the globe are focusing on controlling the rising healthcare costs with the effective utilization of PHM solutions. The successful adoption and implementation of these solutions are expected to save billions of dollars for healthcare systems worldwide. The US Department of Health and Human Services estimates that the widespread adoption of healthcare IT solutions will result in annual savings of USD 80–100 billion by automating care delivery systems and another USD 100 billion by reducing medical errors and wastages across the healthcare system.
Restrains High investments in infrastructure to set up robust PHM program
Population health management is a capital-intensive market. Presently, a majority of healthcare providers across the globe have inadequate infrastructure, which includes technology, staff, data, and other resources to manage complex healthcare cases. To manage an entire population, providers need to heavily invest in infrastructural development. In terms of IT infrastructure, investments are required for increasing storage and processing capabilities. Web-based and mobile tools such as android and iOS apps need to be developed to ensure patient participation and health information exchange.
The investments required to develop this infrastructure will pose a serious restraint to the already strained financial resources of healthcare providers. Additional investments would be required to maintain the infrastructure at the site of care as well as remotely, as healthcare services are expected to be delivered at patients’ homes to increase efficiency and cut costs. In addition, the financial benefits of population health management are not realized immediately, making stakeholders reluctant to make huge investments
Opportunities: Rising focus on personalized medicine
Advanced analytics and predictive modeling applications enable healthcare organizations to treat each patient in a personalized way in order to produce the best possible outcomes. Over the years, analytics has increasingly been applied to personalize the treatment of cancer and other diseases. In this regard, the National Health Service (NHS) in the UK announced an initiative to sequence the genomes of around 100,000 people over a period of five years. A new company named Genomics England Limited was formed to carry out this project, and around USD 160.9 million (GBP 100 million) has been set aside for this project. The information obtained from this project will be used in the treatment and studies of cancer and other rare diseases. The data will also help discover new drug treatments and therapies.
Genomic data can also give insights into the reasons for bacterial and viral resistance to medicines in a population. Additionally, it can help patients with rare diseases understand the origins of their conditions. The availability of relevant data, coupled with the presence of effective analytics tools, will enable doctors to treat their patients in a better way. This, in turn, has the potential to create a new and innovative way of approaching population health management and change the way cancer and other diseases are presently treated around the world.
Additionally, several healthcare organizations and analytics vendors are collaborating to make optimum use of analytics in personalized medicine. For instance, in the US, in February 2021, fourteen leading healthcare providers partnered to form Truveta, a new company that will leverage big data analytics for enhanced care insights. Providers involved in the effort include AdventHealth, Advocate Aurora Health, Baptist Health of Northeast Florida, Bon Secours Mercy Health, CommonSpirit Health, Hawaii Pacific Health, Henry Ford Health System, Memorial Hermann Health System, Northwell Health, Novant Health, Providence health system, Sentara Healthcare, Tenet Health, and Trinity Health. Together, these healthcare providers care for tens of millions of patients and operate thousands of care facilities across 40 states. The health providers will govern Truveta’s ethical pursuit of insights from a de-identified dataset. Such efforts toward precision and personalized medicine are creating an array of opportunities for population health management solution vendors.
Challenges Lack of data management capabilities and skilled analysts
Currently, there are only a limited number of healthcare organizations that have in-house experts who can translate large volumes of data into valuable insights. The lack of data management capabilities and skilled analysts is one of the major barriers to the growth of the population health management market.
The dearth of IT staff in the healthcare industry creates inefficiencies and hinders technological advances like interoperability. According to an article published in December 2015, the need for big data talent in the healthcare industry is expected to increase by 29% in the coming five years. However, changing regulations in the US and various countries across the globe are limiting the hiring of immigrant talent; this, in turn, is expected to weaken the healthcare IT industry in these countries. According to a report published by the US Bureau of Labor Statistics, hospitals and physician practices in the US will need an additional 41,000 professionals in the healthcare information management (HIM) field by 2022. In addition, clinicians employed by referral management centers lack the necessary skills to prioritize patients that urgently need referrals over those that do not need referrals.
Major markets such as Germany, the Netherlands, England, and Australia are also witnessing a significant shortage of HCIT professionals. The lack of in-house IT experts, as well as a trained workforce with cross-functional skills, is expected to hinder the growth of the population health management market during the forecast period.
The Software segment accounted for the largest market share in 2020.
On the basis of component, the population health management market has been segmented into software and services. In 2020, the software segment accounted for the largest share of the market. It is projected to reach USD 34.1 billion by 2026 from USD 17.7 billion in 2021, at a CAGR of 14.0%. The dominance of this segment can be attributed to the increased adoption of software solutions by payers and providers to reduce readmissions, increase cost-effectiveness, improve operational efficiency, enhance patient engagement, and aid data integration and analysis.
The On Premise segment accounted for the largest market share in 2020.
Population health management solutions reach end users through the on-premise and/or cloud-based modes of delivery. The on-premise solutions segment accounted for the larger market share of 63.9% in 2020. The advantages offered by the on-premise mode of delivery, such as customization of solutions, reduction in the risk of data breaches, and the ability to reuse existing servers and storage hardware are supporting its increased adoption in the population health management market.
The Healthcare Providers segment accounted for the largest market share in 2020.
On the basis of end user, the population health management market is segmented into healthcare providers, healthcare payers, and other end users. In 2020, the healthcare providers segment accounted for the largest share of 67.0% of the population health management market. The large share of this segment is attributed to the implementation of the Affordable Care Act and Hospital Readmissions Reduction Program (aimed at lowering healthcare costs by using novel population health management solutions) in the US, as well as the high demand for these solutions among healthcare providers across regions.
North America was the largest regional market for population health management market in 2020
North America accounted for the largest share of 75.1% of the global population health management market in 2020. Factors such as growing federal healthcare mandates to curb the rising healthcare costs, increasing regulatory requirements, growing adoption of EHRs, and rising government initiatives focusing on personalized medicine and value-based reimbursements are expected to drive market growth in North America.
The Asia Pacific market, comprising India, China, Japan, and the Rest of Asia Pacific, offers high-growth opportunities for market players. This regional segment is estimated to register the highest CAGR of 19.1% during the forecast period. The growth of the Asia Pacific population health management market is driven by the rising medical tourism, the implementation of new ICT guidelines in Japan, investments and reforms to modernize China’s healthcare infrastructure, the rapidly growing healthcare industry in India, and the implementation of IT programs in Australia and New Zealand. In addition, government initiatives for the adoption of HCIT, the growing geriatric population, rising prevalence of chronic diseases, increasing healthcare expenditure, and the rising purchasing power of consumers are also expected to support market growth in this region.
Key Market Players
Prominent players in the population health management market include Cerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands), i2i Population Health (US), Health Catalyst (US), Optum (US), Enli Health Intelligence (US), eClinicalWorks (US), Orion Health (New Zealand), Allscripts Healthcare Solutions (US), IBM Corporation (US), HealthEC LLC (US), Medecision (US), Arcadia (US), athenahealth (US), Cotiviti (US), NextGen Healthcare, Inc. (US), Conifer Health Solutions (US), SPH Analytics (US), Lightbeam Health Solutions (US), Innovaccer (US), Citra Health Solutions (US), Evolent Health, Inc. (US), Lumeris (US), and Forward Health Group (US). These companies adopted strategies such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their market presence in the population health management market.
Scope of the report
|
Report Metric |
Details |
|
Market size available for years |
2019-2026 |
|
Base year considered |
2020 |
|
Forecast period |
2021–2026 |
|
Forecast units |
Value (USD) |
|
Segments covered |
By Type of Component, Mode of Delivery, End User and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
|
Companies covered |
The major market players include Cerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands), i2i Population Health (US), Health Catalyst (US), Optum (US), Enli Health Intelligence (US), eClinicalWorks (US), Orion Health (New Zealand), Allscripts Healthcare Solutions (US), IBM Corporation (US), HealthEC LLC (US), Medecision (US), Arcadia (US), athenahealth (US), Cotiviti (US), NextGen Healthcare, Inc. (US), Conifer Health Solutions (US), SPH Analytics (US), Lightbeam Health Solutions (US), Innovaccer (US), Citra Health Solutions (US), Evolent Health, Inc. (US), Lumeris (US), and Forward Health Group (US). |
The study categorizes the population health management market based on By Component, Mode of Delivery and End User at the regional and global level.
By Component
- Software
- Services
By Mode of Delivery
- On Premise Mode of Delivery
- Cloud -Based Mode of Delivery
By End Users
- Healthcare Providers
- Healthcare Payers
- Other End Users
Recent Developments
- In March 2021, Phillips Healthcare (Netherlands) partnered with openDoctor (US). This partnership is aimed at delivering an integrated radiological patient engagement platform that leverages openDoctor’s real-time online appointment scheduling services as part of Philips’ Patient Management Solution.
- In February 2021 Phillips Healthcare (Netherlands) launched Patient Flow Management Solution. The product offers full remote information access and enables a fully portable setup in emergency situations.
- In Decemeber 2020, Cerner (US) acquired a health division of Kantar Group , through this acquisition, Cerner is expected to expand its offering in opportunities in clinical research and population health as it builds its data business.
- In October 2020, Allscripts sold its CarePort Health business (CarePort) for USD 1.35 billion to WellSky Corp.,(US). CarePort solutions assist hundreds of hospitals and thousands of post-acute care providers to efficiently coordinate and transition patients through different settings of care.
- In February 2020, Allscripts partnered with Manorama Infosolutions (India). The partnership was undertaken to enable Manorama integrate the Allscripts interoperability platform, dbMotion Solution with Lifeline Suite of solutions, extending its reach to India and other emerging markets.
Frequently Asked Questions (FAQ):
Which type of component is leading the by type of component segment?
On the basis of component, the population health management market has been segmented into software and services. In 2020, the software segment accounted for the largest share of the market. It is projected to reach USD 34.1 billion by 2026 from USD 17.7 billion in 2021, at a CAGR of 14.0%. The dominance of this segment can be attributed to the increased adoption of software solutions by payers and providers to reduce readmissions, increase cost-effectiveness, improve operational efficiency, enhance patient engagement, and aid data integration and analysis.
Which is the leading mode of delivery segment for Population Health Management market?
Population health management solutions reach end users through the on-premise and/or cloud-based modes of delivery. The on-premise solutions segment accounted for the larger market share of 63.9% in 2020. The advantages offered by the on-premise mode of delivery, such as customization of solutions, reduction in the risk of data breaches, and the ability to reuse existing servers and storage hardware are supporting its increased adoption in the population health management market.
Which is the leading type of end user segment of Population Health Management market?
On the basis of end user, the population health management market is segmented into healthcare providers, healthcare payers, and other end users. In 2020, the healthcare providers segment accounted for the largest share of 67.0% of the population health management market. The large share of this segment is attributed to the implementation of the Affordable Care Act and Hospital Readmissions Reduction Program (aimed at lowering healthcare costs by using novel population health management solutions) in the US, as well as the high demand for these solutions among healthcare providers across regions.
Who are the key players operating in the Population Health Management market?
The Population Health Management market is highly competitive. The prominent players operating in this market are Cerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands), i2i Population Health (US), Health Catalyst (US), Optum (US), Enli Health Intelligence (US), eClinicalWorks (US), Orion Health (New Zealand), Allscripts Healthcare Solutions (US), IBM Corporation (US), HealthEC LLC (US), Medecision (US), Arcadia (US), athenahealth (US), Cotiviti (US), NextGen Healthcare, Inc. (US), Conifer Health Solutions (US), SPH Analytics (US), Lightbeam Health Solutions (US), Innovaccer (US), Citra Health Solutions (US), Evolent Health, Inc. (US), Lumeris (US), and Forward Health Group (US).
Which geographical region is dominating in Population Health Management market?
The population health management market studied in this report is divided into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of 75.1% of the global population health management market in 2020. Factors such as growing federal healthcare mandates to curb the rising healthcare costs, increasing regulatory requirements, growing adoption of EHRs, and rising government initiatives focusing on personalized medicine and value-based reimbursements are expected to drive market growth in North America.
The Asia Pacific market, comprising India, China, Japan, and the Rest of Asia Pacific, offers high-growth opportunities for market players. This regional segment is estimated to register the highest CAGR of 19.1% during the forecast period. The growth of the Asia Pacific population health management market is driven by the rising medical tourism, the implementation of new ICT guidelines in Japan, investments and reforms to modernize China’s healthcare infrastructure, the rapidly growing healthcare industry in India, and the implementation of IT programs in Australia and New Zealand. In addition, government initiatives for the adoption of HCIT, the growing geriatric population, rising prevalence of chronic diseases, increasing healthcare expenditure, and the rising purchasing power of consumers are also expected to support market growth in this region. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 29)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 33)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION: POPULATION HEALTH MANAGEMENT MARKET
2.2.1 APPROACH 1: BOTTOM-UP APPROACH; DEMAND-SIDE ANALYSIS
FIGURE 5 BOTTOM-UP APPROACH: DEMAND-SIDE ANALYSIS
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 7 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET
2.7 COVID-19 HEALTH ASSESSMENT
2.8 COVID-19 ECONOMIC ASSESSMENT
2.9 ASSESSMENT OF IMPACT OF COVID-19 ON ECONOMIC SCENARIO
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 46)
FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
FIGURE 12 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2021 VS. 2026 (USD MILLION)
FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS (Page No. - 50)
4.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW
FIGURE 15 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS - MAJOR DRIVER FOR MARKET GROWTH
4.2 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER AND COUNTRY (2020)
FIGURE 16 JAPAN ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2020
4.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 REGIONAL MIX: POPULATION HEALTH MANAGEMENT MARKET (2021−2026)
FIGURE 18 NORTH AMERICA TO DOMINATE POPULATION HEALTH MANAGEMENT MARKET DURING FORECAST PERIOD
4.5 POPULATION HEALTH MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 54)
5.1 INTRODUCTION
TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Government mandates & support for healthcare IT solutions
5.2.1.2 Need to curtail escalating healthcare costs
5.2.1.3 Rising geriatric population and subsequent growth in burden of chronic diseases
5.2.2 RESTRAINTS
5.2.2.1 High investments in infrastructure to set up robust PHM program
5.2.2.2 Data breach concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Rising focus on personalized medicine
5.2.3.3 Increasing focus on value-based medicine
5.2.4 CHALLENGES
5.2.4.1 Lack of data management capabilities and skilled analysts
5.2.4.2 Interoperability issues
6 INDUSTRY INSIGHTS (Page No. - 62)
6.1 INDUSTRY TRENDS
6.1.1 NEED FOR INTEROPERABILITY & INTEGRATION DRIVING INNOVATION IN POPULATION HEALTH MANAGEMENT MARKET
6.1.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
6.1.3 GROWING DEMAND FOR PATIENT-CENTRIC HEALTHCARE
FIGURE 20 VALUE-BASED CARE WORKFLOW
6.1.4 CLOUD-BASED IT SOLUTIONS
6.1.5 CONSOLIDATION OF HEALTHCARE PROVIDERS
6.2 COVID-19 IMPACT ANALYSIS
6.2.1 IMPACT OF COVID-19 ON POPULATION HEALTH MANAGEMENT MARKET
6.3 ECOSYSTEM
FIGURE 21 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM
6.4 EVOLUTION OF ACCOUNTABLE CARE ORGANIZATIONS (ACOS): A PROMISING PAYMENT REFORM
6.4.1 INTRODUCTION
FIGURE 22 ACO: REIMBURSEMENT MODEL
6.4.2 US: EVOLUTION OF ACOS
FIGURE 23 EVOLUTION OF ACO MODELS
FIGURE 24 US: TOTAL PUBLIC & PRIVATE ACCOUNTABLE CARE ORGANIZATIONS (2011–2015)
6.4.3 ROLE OF INFORMATION TECHNOLOGY IN ACCOUNTABLE CARE
FIGURE 25 ACCOUNTABLE CARE SOLUTIONS AND THEIR USE
6.5 HCIT EXPENDITURE ANALYSIS
6.5.1 NORTH AMERICA
TABLE 4 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
6.5.2 EUROPE
6.5.3 ASIA PACIFIC
TABLE 5 JAPAN : HEALTHCARE IT INITIATIVES AND FUNDING
TABLE 6 CHINA : HEALTHCARE IT INITIATIVES AND FUNDING
6.6 REGULATORY ANALYSIS
6.6.1 NORTH AMERICA
6.6.2 EUROPE
6.6.3 ASIA PACIFIC
6.7 PORTER’S FIVE FORCES ANALYSIS
FIGURE 26 DEGREE OF COMPETITION IS HIGH IN POPULATION HEALTH MANAGEMENT MARKET
TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
7 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT (Page No. - 76)
7.1 INTRODUCTION
TABLE 8 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 9 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
7.2 SOFTWARE
7.2.1 SOFTWARE - LARGEST COMPONENT OF POPULATION HEALTH MANAGEMENT MARKET
TABLE 10 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 11 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 12 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
7.3 SERVICES
7.3.1 INDISPENSABLE & RECURRING NATURE OF SERVICES TO DRIVE PHM MARKET GROWTH
TABLE 13 POPULATION HEALTH MANAGEMENT SERVICES OFFERED BY KEY MARKET PLAYERS
TABLE 14 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 15 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
8 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY (Page No. - 85)
8.1 INTRODUCTION
TABLE 16 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 17 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
8.2 ON-PREMISE MODE OF DELIVERY
8.2.1 TRADITIONAL ON-PREMISE DEPLOYMENT ALLOWS TIME TO TEST SOFTWARE UPGRADES BEFORE IMPLEMENTATION
TABLE 18 ON-PREMISE MODE OF DELIVERY: PROS & CONS
TABLE 19 POPULATION HEALTH MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 20 POPULATION HEALTH MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020–2026 (USD MILLION)
8.3 CLOUD-BASED MODE OF DELIVERY
8.3.1 CLOUD-BASED DELIVERY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 21 CLOUD-BASED MODE OF DELIVERY: PROS & CONS
TABLE 22 POPULATION HEALTH MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 23 POPULATION HEALTH MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020–2026 (USD MILLION)
9 POPULATION HEALTH MANAGEMENT MARKET, BY END USER (Page No. - 92)
9.1 INTRODUCTION
TABLE 24 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 25 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
9.2 HEALTHCARE PROVIDERS
9.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS BOOSTS USE OF PHM SOLUTIONS
TABLE 26 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 27 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2026 (USD MILLION)
9.3 HEALTHCARE PAYERS
9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS DRIVES DEMAND FOR PHM SOLUTIONS AMONG HEALTHCARE PAYERS
TABLE 28 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 29 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2026 (USD MILLION)
9.4 OTHER END USERS
TABLE 30 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 31 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2026 (USD MILLION)
10 POPULATION HEALTH MANAGEMENT MARKET, BY REGION (Page No. - 100)
10.1 INTRODUCTION
TABLE 32 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2017–2019 (USD MILLION)
TABLE 33 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2020–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
TABLE 34 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 35 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 37 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 39 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 41 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.2.1 US
10.2.1.1 US is largest market for population health management solutions
TABLE 42 US: MACROECONOMIC INDICATORS
TABLE 43 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 44 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 45 US: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 46 US: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 47 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 48 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Deployment of digital health initiatives boosts market growth in Canada
TABLE 49 CANADA: MACROECONOMIC INDICATORS
TABLE 50 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 51 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 52 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 53 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 54 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 55 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3 EUROPE
TABLE 56 EUROPE: E-HEALTH PRIORITIES FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019
TABLE 57 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 58 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 59 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 60 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 61 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 62 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 63 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 64 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany dominates European population health management market
TABLE 65 GERMANY: MACROECONOMIC INDICATORS
TABLE 66 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 67 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 68 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 69 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 70 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 71 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.2 UK
10.3.2.1 Increasing public-private initiatives support adoption of PHM solutions in UK
TABLE 72 UK: MACROECONOMIC INDICATORS
TABLE 73 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 74 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 75 UK: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 76 UK: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 77 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 78 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing patient volume for chronic and age-related conditions to drive market in France
TABLE 79 FRANCE: MACROECONOMIC INDICATORS
TABLE 80 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 81 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 82 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 83 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 84 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 85 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Government initiatives to support market growth in Italy
TABLE 86 ITALY: MACROECONOMIC INDICATORS
TABLE 87 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 88 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 89 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 90 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 91 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 92 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing adoption of PHM solutions in Spain driven by demand for e-prescriptions and better patient record management
TABLE 93 SPAIN: MACROECONOMIC INDICATORS
TABLE 94 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 95 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 96 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 97 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 98 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 99 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 100 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 101 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 102 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 103 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 104 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 105 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
TABLE 106 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
TABLE 107 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 108 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 109 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 111 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 113 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan accounted for largest share of PHM market in Asia Pacific in 2020
TABLE 114 JAPAN: MACROECONOMIC INDICATORS
TABLE 115 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 116 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 117 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 118 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 119 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 120 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Market in China driven by strong government support
TABLE 121 CHINA: MACROECONOMIC INDICATORS
TABLE 122 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 123 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 124 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 125 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 126 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 127 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing volume of patient data generated within healthcare systems to drive market in India
TABLE 128 INDIA: MACROECONOMIC INDICATORS
TABLE 129 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 130 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 131 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 132 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 133 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 134 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 135 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET,BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 136 REST OF ASIA PACIFIC : POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC : POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 138 REST OF ASIA PACIFIC : POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 139 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 140 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 BRAZIL, ARGENTINA, AND MEXICO ARE EMERGING HEALTHCARE MARKETS IN LATIN AMERICA
TABLE 141 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 142 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 143 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 144 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 145 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 146 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE PROPEL MARKET GROWTH IN MIDDLE EAST & AFRICA
TABLE 147 MIDDLES EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2017–2019 (USD MILLION)
TABLE 148 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2026 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET,BY MODE OF DELIVERY, 2017–2019 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2026 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2017–2019 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 156)
11.1 INTRODUCTION
FIGURE 29 KEY DEVELOPMENTS OF SOME OF THE MAJOR PLAYERS BETWEEN 2017 AND APRIL 2021
11.2 MARKET EVALUATION FRAMEWORK
FIGURE 30 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS —THE MOST WIDELY ADOPTED STRATEGY
11.3 POPULATION HEALTH MANAGEMENT MARKET: R&D EXPENDITURE
FIGURE 31 R&D EXPENDITURE OF KEY PLAYERS IN THE POPULATION HEALTH MANAGEMENT MARKET (2019 VS. 2020)
11.4 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 32 POPULATION HEALTH MANAGEMENTMARKET: REVENUE ANALYSIS OF KEY MARKET PLAYERS (2020)
11.5 VENDOR DIVE
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 EMERGING COMPANIES
FIGURE 33 COMPETITIVE LEADERSHIP MAPPING: POPULATION HEALTH MANAGEMENT MARKET, 2020
11.6 KEY PLAYERS ANALYSIS
FIGURE 34 POPULATION HEALTH MANAGEMNT MARKET ANALYSIS BY VENDOR TYPE
11.7 COMPETITIVE SITUATIONS AND TRENDS
11.7.1 PRODUCT LAUNCHES
11.7.2 DEALS
11.7.3 OTHER DEVELOPMENTS
11.8 COMPETITIVE LEADERSHIP MAPPING – START-UP/SME
11.8.1 PROGRESSIVE COMPANIES
11.8.2 STARTING BLOCKS
11.8.3 RESPONSIVE COMPANIES
11.8.4 DYNAMIC COMPANIES
FIGURE 35 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
12 COMPANY PROFILES (Page No. - 166)
12.1 KEY PLAYERS
(Business Overview, Solutions offered, Recent Developments, and MNM View)*
12.1.1 CERNER CORPORATION
TABLE 153 CERNER CORPORATION: BUSINESS OVERVIEW
FIGURE 36 CERNER CORPORATION: COMPANY SNAPSHOT (2020)
12.1.2 ALLSCRIPTS HEALTHCARE SOLUTIONS
TABLE 154 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: BUSINESS OVERVIEW
FIGURE 37 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2020)
12.1.3 IBM CORPORATION
TABLE 155 IBM CORPORATION: BUSINESS OVERVIEW
FIGURE 38 IBM CORPORATION: COMPANY SNAPSHOT (2020)
12.1.4 EPIC SYSTEMS CORPORATION
TABLE 156 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
12.1.5 KONINKLIJKE PHILIPS
TABLE 157 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 39 PHILLIPS HEALTHCARE: COMPANY SNAPSHOT (2020)
12.1.6 I2I POPULATION HEALTH
TABLE 158 I2I POPULATION HEALTH: BUSINESS OVERVIEW
12.1.7 HEALTH CATALYST
TABLE 159 HEALTH CATALYST: BUSINESS OVERVIEW
FIGURE 40 HEALTH CATALYST: COMPANY SNAPSHOT (2020)
12.1.8 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP)
TABLE 160 OPTUM, INC: BUSINESS OVERVIEW
FIGURE 41 OPTUM: COMPANY SNAPSHOT (2020)
12.1.9 ENLI HEALTH INTELLIGENCE ( A CEDAR GROUP TECHNOLOGIES)
TABLE 161 ENLI HEALTH INTELLIGENCE: BUSINESS OVERVIEW
12.1.10 ECLINICALWORKS
TABLE 162 ECLINICALWORKS: BUSINESS OVERVIEW
12.1.11 HEALTHEC, LLC
TABLE 163 HEALTHEC LLC: BUSINESS OVERVIEW
12.1.12 MEDECISION
TABLE 164 MEDECISION: BUSINESS OVERVIEW
12.1.13 ARCADIA
TABLE 165 ARCADIA: BUSINESS OVERVIEW
12.1.14 ATHENAHEALTH
TABLE 166 ATHENAHEALTH, INC: BUSINESS OVERVIEW
12.1.15 COTIVITI (VERSCEND TECHNOLOGIES)
TABLE 167 COTIVITI: BUSINESS OVERVIEW
12.1.16 NEXTGEN HEALTHCARE, INC.
TABLE 168 NEXTGEN HEALTHCARE, INC.: BUSINESS OVERVIEW
FIGURE 42 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2020)
12.2 OTHER EMERGING PLAYERS
12.2.1 CONIFER HEALTH SOLUTIONS
12.2.2 SPH ANALYTICS
12.2.3 LIGHTBEAM HEALTH SOLUTIONS
12.2.4 INNOVACCER
*Details on Business Overview, Solutions offered, Recent Developments, and MNM View might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 209)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved four major activities for estimating the current size of the population health management market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Revenue Share Analysis, Parent Market, bottom-up and top-down approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.
Secondary Research
In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources include annual reports, press releases and investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the population health management market. Primary sources from the demand side include experts from pharma and bio pharma companies, experts from food industry and research centers. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on the key industry trends and key market dynamics, such as market drivers, restraints, challenges, and opportunities.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the population health management market was arrived at after data triangulation from two different approaches, as mentioned below.
Approach to calculate the revenue of different players in the population health management market
The size of the population health management market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global population health management market was derived.
Approach to derive the market size and estimate market growth
The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
Data Triangulation
After arriving at the overall market size-using the market size estimation processes explained above-the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Objectives of the Study
- To define, describe, and forecast the size of the population health management market on the basis of component, mode of delivery, end user, and region
- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to five regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East & Africa
- To strategically analyze the market structure and profile the key players in the population health management market and comprehensively analyze their core competencies3
- To track and analyze company developments such as agreements, collaborations, partnerships, acquisitions, expansions, and solution launches & enhancements in the population health management market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top companies
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific market into Australia, South Korea, New Zealand, Hong Kong, Singapore, and other countries
- Further breakdown of the Rest of Europe market into Russia, Switzerland, the Netherlands, Nordic countries, and other countries
Company Information
- Detailed analysis and profiling of additional market players (Up to five)
Get in-depth analysis of the COVID-19 impact on the Population Health Management Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Population Health Management Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Population Health Management Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Population Health Management Market